相关实验视频
Updated: Jan 17, 2026

08:12
Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
3.4K
减弱ELOVL6活动会诱导突变KRAS降解
Xiyue Hu1, Ranjit Singh Atwal1,2, Sophie Xiao1
1Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Nature chemical biology
|September 15, 2025
概括
研究人员确定脂肪酸延长酶6 (ELOVL6) 是减少癌症中KRAS-G12V基蛋白的关键标. 这一发现为新的KRAS-G12V特异性癌症疗法铺平了道路.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- KRAS突变在癌症中很常见,但由于细微的结构变化,很难准它们.
- 虽然KRAS-G12C是向的,但KRAS-G12V的有效疗法仍然难以捉摸.
- 识别KRAS-G12V的特定漏洞对于开发新的癌症治疗方法至关重要.
研究的目的:
- 为了识别特定调节KRAS-G12V突变的基因.
- 探索ELOVL6作为KRAS-G12V驱动癌症的潜在治疗标.
- 了解ELOVL6影响KRAS-G12V的机制.
主要方法:
- 使用CRISPR-Cas9全基因组淘汰屏幕来识别KRAS-G12V的调节器.
- 分析了蛋白质表达水平和瘤信号通路.
- 研究了与KRAS-G12V功能相关的脂生产途径.
主要成果:
- 确定ELOVL6是一个顶级打击,选择性地减少KRAS-G12V蛋白质表达.
- 准ELOVL6减少了由KRAS-G12V驱动的异常致癌信号.
- 发现ELOVL6调节了对KRAS-G12V功能至关重要的脂生产.
结论:
- 对于KRAS-G12V突变的癌症来说,ELOVL6是一个有前途的治疗标.
- 准ELOVL6可能导致KRAS-G12Vcoprotein的降解.
- 这项研究为开发针对KRAS-G12V的新型小分子抑制剂提供了基础.
相关概念视频
The Ras Gene
7.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.1K
Small GTPases - Ras and Rho
5.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.2K
Export of Misfolded Proteins out of the ER
5.0K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.0K

